Dr. Thomas Kaley, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Brain Tumor
Studies Glioblastoma
14 reported clinical trials
22 drugs studied
Area of expertise
1Brain Tumor
IDH positive
Stage III
Stage II
2Glioblastoma
IDH negative
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Thomas Kaley, MD is currently running
REC-2282
for Meningioma
This trial is testing a new drug called REC-2282 to see if it can help treat specific brain tumors in patients who haven't responded to other treatments. The study will check if the drug can slow down or stop the growth of these tumors.
Recruiting0 awards Phase 2 & 35 criteria
Triple Therapy
for Brain Cancer
This study will test the safety and effectiveness of a combination of pembrolizumab, olaparib, and temozolomide to see how well these drugs work when given together in people with a glioma that either did not respond to previous treatment or came back after treatment.
Recruiting1 award Phase 230 criteria
More about Thomas Kaley, MD
Clinical Trial Related5 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Thomas Kaley, MD has experience with
- Abemaciclib
- Pembrolizumab
- Temozolomide
- AB-218
- MRI Perfusion
- PET/CT Scans
Breakdown of trials Thomas Kaley, MD has run
Brain Tumor
Glioblastoma
Recurrence
Malignant Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Thomas Kaley, MD specialize in?
Thomas Kaley, MD focuses on Brain Tumor and Glioblastoma. In particular, much of their work with Brain Tumor has involved IDH positive patients, or patients who are Stage III.
Is Thomas Kaley, MD currently recruiting for clinical trials?
Yes, Thomas Kaley, MD is currently recruiting for 5 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Thomas Kaley, MD has studied deeply?
Yes, Thomas Kaley, MD has studied treatments such as Abemaciclib, Pembrolizumab, Temozolomide.
What is the best way to schedule an appointment with Thomas Kaley, MD?
Apply for one of the trials that Thomas Kaley, MD is conducting.
What is the office address of Thomas Kaley, MD?
The office of Thomas Kaley, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.